Description
Understanding YK-11: Properties and Chemical Composition
YK-11, a notable compound in the realm of selective androgen receptor modulators (SARMs), possesses a chemical formula of C25H34O6, signifying a complex yet intriguing molecular structure. With a molecular mass of approximately 430.541 g/mol, YK-11 demonstrates the characteristics typical of synthetic steroidal compounds. The International Union of Pure and Applied Chemistry (IUPAC) recognizes its full name as (1S,3S,5R,6S,8S,10R,11R,12R)-6,11-dihydroxy-10,12-dimethyl-3-[(2S)-2-methyl-1,3-oxazolidin-4-yl]spiro[3.3]nonan-1-one, which reflects its intricate stereochemical nature.
YK-11 is assigned a Chemical Abstracts Service (CAS) number of 1370003-76-1, which is crucial for identification in scientific literature and regulatory frameworks. Furthermore, its PubChem ID is 119058028, allowing researchers to access extensive data on its properties, biological activities, and potential applications. These identifiers are essential not only for ensuring accurate communication among scientists but also for navigating the compound’s regulatory landscape.
As a synthetic steroidal SARM, YK-11 is distinguished by its ability to selectively target androgen receptors, which has significant implications for muscle mass and strength enhancement. Animal studies, notably one published in the 2013 Biological and Pharmaceutical Bulletin, have illustrated the potential benefits of YK-11 in promoting muscle growth and improving strength parameters. Such findings pave the way for further exploration of YK-11’s effectiveness and safety in human applications.
In terms of formulation, YK-11 is commonly available in capsules containing an active ingredient amount of 5mg per 60 capsules. Its stability is further enhanced by a shelf life of 36 months, making it a reliable option for those exploring its anabolic potential. The unique properties of YK-11, coupled with its targeted action and regulatory identification, make it a notable compound within the SARM category.
The Scientific Backing of YK-11: Research and Findings
YK-11, a selective androgen receptor modulator (SARM), has garnered attention in the fitness and athletic communities due to its potential anabolic properties. The scientific research surrounding YK-11 is still in its early stages, but several key studies have provided valuable insights into its effects on muscle mass and strength, which are critical for understanding its viability as a performance-enhancing compound.
One of the seminal studies conducted in 2013 investigated the effects of YK-11 on muscle cells. In this study, researchers employed myoblast cells, which are precursors to muscle fibers, to assess the compound’s efficacy. The results suggested that YK-11 significantly increased the expression of follistatin, a protein that inhibits myostatin – a negative regulator of muscle growth. This indicated that YK-11 might facilitate greater muscle gains by counteracting myostatin’s effects. Through a meticulous laboratory approach, the findings proposed that YK-11 could promote muscle hypertrophy without the adverse side effects commonly associated with traditional anabolic steroids.
Moreover, subsequent animal studies have echoed these initial findings, demonstrating that YK-11 can enhance lean body mass and improve strength metrics in non-human subjects. Notably, these investigations highlighted that YK-11 does not compromise liver or organ health, a paramount concern when evaluating the safety of performance-enhancing substances. While these results are promising, it is important to note that the majority of research has been conducted on animal models, and human research is still limited.
As such, the implications for both athletes and researchers are significant. Athletes may perceive YK-11 as a potential alternative for improving performance while minimizing the risk of damage to vital organs. Researchers, on the other hand, are urged to continue exploring YK-11’s anabolic properties and safety profile in controlled human trials to validate its efficacy and address existing concerns. This ongoing exploration could reveal a new frontier in muscle-building supplements, balancing effectiveness with safety in athletic performance.
